FDA Approved: LEVETIRACETAM — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a Civica, Inc. supplemental application for Levetiracetam, approving changes to the generic product. The product is indicated for partial-onset sei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Tonic-clonic Seizures
• Juvenile Myoclonic Epilepsy
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)